Advances in Interventional Cardiology
eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current Issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2026
vol. 22
 
Share:
Share:
Original paper

Prognostic value of the hemoglobin–albumin– lymphocyte–platelet (HALP) score for long-term mortality after transcatheter aortic valve implantation

Mustafa Ferhat Keten
1
,
Seda Tanyeri Uzel
1
,
Ahmet Karaduman
2
,
Busra Guvendi Sengor
1
,
Cemalettin Yılmaz
3
,
Halit Eminoglu
1
,
Baver Bozan
1
,
Tezel Kovanci
1
,
Ismail Balaban
1
,
Regayip Zehir
1

  1. Department of Cardiology, Koşuyolu High Specialization Training and Research Hospital, Istanbul, Turkey
  2. Emsey Hospital, Department of Cardiology, Istanbul, Turkey
  3. Department of Cardiology, Yalova University School of Medicine, Yalova, Turkey
Adv Interv Cardiol 2026; 22, 1 (83): 70–79
Online publish date: 2026/03/16
Article file
- Prognostic.pdf  [0.21 MB]
Get citation
 
 
1. Généreux P, Sharma RP, Cubeddu RJ, et al. The mortality burden of untreated aortic stenosis. J Am Coll Cardiol 2023; 82: 2101-9.
2. Praz F, Borger MA, Lanz J, et al. 2025 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2025; 46: 4635-6.
3. Gleason TG, Reardon MJ, Popma JJ, et al. 5-year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients. J Am Coll Cardiol 2018; 72: 2687-96.
4. Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015; 385: 2477-84.
5. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016; 374: 1609-20.
6. Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 2019; 380: 1706-15.
7. Giordana F, D’Ascenzo F, Nijhoff F, et al. Meta-analysis of predictors of all-cause mortality after transcatheter aortic valve implantation. Am J Cardiol 2014; 114: 1447-55.
8. Duncan A, Ludman P, Banya W, et al. Long-term outcomes after transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis. JACC Cardiovasc Interv 2015; 8: 645-53.
9. Maeda K, Kumamaru H, Kohsaka S, et al. A risk model for 1-year mortality after transcatheter aortic valve replacement from the J-TVT Registry. JACC Asia 2022; 2: 635-44.
10. Holmes DR, Brennan JM, Rumsfeld JS, et al. Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA 2015; 313: 1019-28.
11. Siddiqi TJ, Usman MS, Khan MS, et al. Systematic review and meta-analysis of current risk models in predicting short-term mortality after transcatheter aortic valve replacement. EuroIntervention 2020; 15: 1497-505.
12. Silva LS, Caramori PRA, Nunes Filho ACB, et al. Performance of surgical risk scores to predict mortality after transcatheter aortic valve implantation. Arq Bras Cardiol 2015; 105: 241-7.
13. Vivendar S, Lv W, Hagar A, et al. The impact of nutritional status on the outcome of transcatheter aortic valve implantation. Heart Surgery Forum 2022; 25: E267-72.
14. Malik AH, Yandrapalli S, Zaid S, et al. Impact of frailty on mortality, readmissions, and resource utilization after TAVI. Am J Cardiol 2020; 127: 120-7.
15. Mazzone A, Venneri L, Berti S. Aortic valve stenosis and coronary artery disease: pathophysiological and clinical links. J Cardiovasc Med 2007; 8: 983-9.
16. Abdul-Rahman T, Lizano-Jubert I, Garg N, et al. The common pathobiology between coronary artery disease and calcific aortic stenosis: evidence and clinical implications. Prog Cardiovasc Dis 2023; 79: 89-99.
17. Novo G, Guarneri FP, Ferro G, et al. Association between asymptomatic carotid atherosclerosis and degenerative aortic stenosis. Atherosclerosis 2012; 223: 519-22.
18. Tosu AR, Kalyoncuoglu M, Biter Hİ, et al. Prognostic value of Systemic Immune-Inflammation Index for major adverse cardiac events and mortality in severe aortic stenosis patients after TAVI. Medicina (B Aires) 2021; 57: 588.
19. Takagi H, Kuno T, Hari Y, et al. Prognostic impact of baseline C‐reactive protein levels on mortality after transcatheter aortic valve implantation. J Card Surg 2020; 35: 974-80.
20. Manolis AA, Manolis TA, Melita H, et al. Low serum albumin: a neglected predictor in patients with cardiovascular disease. Eur J Intern Med 2022; 102: 24-39.
21. Tonet E, Campo G, Maietti E, et al. Nutritional status and all-cause mortality in older adults with acute coronary syndrome. Clin Nutr 2020; 39: 1572-9.
22. Xu SS, Li S, Xu HX, et al. Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer. World J Gastroenterol 2020; 26: 828-38.
23. Pan H, Lin S. Association of hemoglobin, albumin, lymphocyte, and platelet score with risk of cerebrovascular, cardiovascular, and all-cause mortality in the general population: results from the NHANES 1999-2018. Front Endocrinol (Lausanne) 2023; 14: 1173399.
24. Yılmaz C, Ungan I, Arslan E, et al. The HALP Score’s Prognostic Value for the elderly (≥ 75 years) patients following percutaneous coronary intervention for acute myocardial infarction. Turk Kardiyol Dern Ars 2025; 53: 388-97.
25. Dweck MR, Loganath K, Bing R, et al. Multi-modality imaging in aortic stenosis: an EACVI clinical consensus document. Eur Heart J Cardiovasc Imaging 2023; 24: 1430-43.
26. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28: 1-39.e14.
27. Zheng Y, Huang Y, Li H. Hemoglobin albumin lymphocyte and platelet score and all-cause mortality in coronary heart disease: a retrospective cohort study of NHANES database. Front Cardiovasc Med 2023; 10: 1241217.
28. Liu H, Zhang F, Li Y, et al. The HALP score predicts no-reflow phenomenon and long-term prognosis in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention. Coron Artery Dis 2025; 36: 273-80.
29. Cao Z, Chen N, Jiang H, et al. Association between the Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score and adverse outcomes in critically ill patients with acute myocardial infarction: a retrospective study and machine learning analysis. Rev Cardiovasc Med 2025; 26: 43942.
30. Liu L, Gong B, Wang W, et al. Association between haemoglobin, albumin, lymphocytes, and platelets and mortality in patients with heart failure. ESC Heart Fail 2024; 11: 1051-60.
31. Broussier A, Valembois L, Lafuente-Lafuente C, et al. Apports de l’évaluation gérontologique pour les patients cardiovasculaires très âgés. Presse Med 2019; 48: 120-6.
32. Almasaudi AS, Dolan RD, Edwards CA, et al. Hypoalbuminemia reflects nutritional risk, body composition and systemic inflammation and is independently associated with survival in patients with colorectal cancer. Cancers (Basel) 2020; 12: 1986.
33. Lee CT, Chen MZ, Yip CYC, et al. Prevalence of anemia and its association with frailty, physical function and cognition in community-dwelling older adults: findings from the HOPE Study. J Nutr Health Aging 2021; 25: 679-87.
34. Zidar DA, Al-Kindi SG, Liu Y, et al. Association of lymphopenia with risk of mortality among adults in the US general population. JAMA Netw Open 2019; 2: e1916526.
35. Sorysz D, Dziewierz A, Gawlik K, et al. Temporal changes in biomarker levels and their association with the early degeneration stage of transcatheter aortic valves in 18F-fluorodeoxyglucose and 18F-sodium fluoride positron emission tomography studies. Adv Interv Cardiol 2024; 20: 329-37.
36. Błaszkiewicz M, Aleksandrowicz KA, Mazur M, et al. Prevalence of iron deficiency and its influence on six-minute walk test distance in patients eligible for transcatheter aortic valve implantation. A prospective study. Adv Interv Cardiol 2024; 20: 443-8.
37. Bogdan A, Barbash IM, Segev A, et al. Albumin correlates with all-cause mortality in elderly patients undergoing transcatheter aortic valve implantation. EuroIntervention 2016; 12: e1057-64.
38. Rawat A, Goyal P, Ahsan SA, et al. The prognostic value of neutrophil-to-lymphocyte ratio on mortality in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis. Cureus 2025; 17: e77909.
39. Gitmez M, Güzel T, Kis M, et al. The performance of the NAPLES prognostic score in predicting one-year mortality and major adverse cardiovascular events after transcatheter aortic valve implantation in patients with severe aortic stenosis. Pol Heart J 2025; 83: 287-94.
40. Lertsanguansinchai P, Chokesuwattanaskul R, Petchlorlian A, et al. Machine learning-based predictive risk models for 30-day and 1-year mortality in severe aortic stenosis patients undergoing transcatheter aortic valve implantation. Int J Cardiol 2023; 374: 20-6.
41. Gomes B, Pilz M, Reich C, et al. Machine learning-based risk prediction of intrahospital clinical outcomes in patients undergoing TAVI. Clin Res Cardiol 2021; 110: 343-56.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Quick links
© 2026 Termedia Sp. z o.o.
Developed by Termedia.